<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633044</url>
  </required_header>
  <id_info>
    <org_study_id>PIC-206-19</org_study_id>
    <nct_id>NCT04633044</nct_id>
  </id_info>
  <brief_title>Maternal Betaine Supplementation During Breastfeeding</brief_title>
  <official_title>Maternal Betaine Supplementation During Breastfeeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Sant Joan de Déu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Sant Joan de Déu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Developing more efficient and cost-effective prevention strategies to slow down the worldwide&#xD;
      epidemic of obesity and chronic metabolic disease has become a public health imperative. Our&#xD;
      previous results in humans demonstrate that lower breast milk betaine levels were associated&#xD;
      with faster infant postnatal growth, a strong and potentially modifiable risk factor of&#xD;
      future obesity. Betaine is a trimethylated derivative of glycine, which is present in&#xD;
      multiple foods and occurs naturally in breast milk. In this study, we will perform a&#xD;
      double-blind randomized placebo-controlled pilot clinical study, in which maternal diet will&#xD;
      be supplemented with betaine for 3 months during breastfeeding; infant's growth and adiposity&#xD;
      will be monitored until 12 months of age, and breast milk composition and gut microbiota&#xD;
      analyzed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 11, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized placebo-controlled study with maternal dietary supplementation (betaine or placebo) for 3 months starting at infant birth and follow-up until 12 months of age.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from birth weight-for-length z score at 1 month</measure>
    <time_frame>Birth and 1 month</time_frame>
    <description>Weight and length will be measured at different time-points and combined to calculate weight-for-length z scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from birth weight-for-length z score at 3 months</measure>
    <time_frame>Birth and 3 months</time_frame>
    <description>Weight and length will be measured at different time-points and combined to calculate weight-for-length z scores.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from birth weight-for-length z score at 6 months</measure>
    <time_frame>Birth and 6 months</time_frame>
    <description>Weight and length will be measured at different time-points and combined to calculate weight-for-length z scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from birth weight-for-length z score at 12 months</measure>
    <time_frame>Birth and 12 months</time_frame>
    <description>Weight and length will be measured at different time-points and combined to calculate weight-for-length z scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant Body composition</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>Total body and abdominal fat mass measured by DXA scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast milk concentration of betaine and related metabolites</measure>
    <time_frame>1 and 3 months</time_frame>
    <description>We will quantify betaine and related metabolites in maternal breast milk samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal circulating concentration of betaine and related metabolites</measure>
    <time_frame>1 and 3 months</time_frame>
    <description>We will quantify betaine and related metabolites in maternal plasma samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant urine concentration of betaine and related metabolites</measure>
    <time_frame>1, 3, and 6, and 12 months</time_frame>
    <description>We will quantify betaine and related metabolites in infant urine samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant gut microbiome composition</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>DNA from infant fecal samples will be sequenced to quantify abundance of the different bacterial groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal gut microbiome composition</measure>
    <time_frame>1 and 3 months</time_frame>
    <description>DNA from maternal fecal samples will be sequenced to quantify abundance of the different bacterial groups.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Breast milk microbiota composition</measure>
    <time_frame>1 and 3 months</time_frame>
    <description>DNA from breast milk samples will be sequenced to quantify abundance of the different bacterial groups.</description>
  </other_outcome>
  <other_outcome>
    <measure>Breast milk metabolome</measure>
    <time_frame>1 and 3 months</time_frame>
    <description>Liquid chromatography coupled to mass spectrometry will be used to obtain a comprehensive metabolic profile of breast milk samples</description>
  </other_outcome>
  <other_outcome>
    <measure>Child development (ASQ-3 questionnaire)</measure>
    <time_frame>1, 3, 6, and 12 months</time_frame>
    <description>Developmental progress will be evaluated with the parental reported ASQ-3 questionnaires</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>400 mg of lactose daily for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg of betaine daily for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Betaine</intervention_name>
    <description>The intervention with supplement will start during the first 48h after birth and will last for 12 weeks</description>
    <arm_group_label>Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The intervention with supplement will start during the first 48h after birth and will last for 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Maternal Pre-pregnancy BMI between 25 and 40.&#xD;
&#xD;
          -  Willing to exclusively breastfeed for ≥ 3 months&#xD;
&#xD;
          -  Infant gestational age at birth &gt; 37 weeks&#xD;
&#xD;
          -  Infant birth weigth &gt; -1 standard deviations&#xD;
&#xD;
          -  Absence of infant disease or malformations at birth&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Lactose intolerance&#xD;
&#xD;
          -  CBS deficiency (inherited disease)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Carles Lerin, PhD</last_name>
    <phone>(+34) 93 600 97 51</phone>
    <email>clerin@fsjd.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Sant Joan de Deu</name>
      <address>
        <city>Barcelona</city>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carles Lerin, PhD</last_name>
      <phone>(+34) 93 600 97 51</phone>
      <email>clerin@fsjd.org</email>
    </contact>
    <contact_backup>
      <last_name>Marta Ramon Krauel, MD PhD</last_name>
      <phone>(+34) 93 280 40 00</phone>
      <phone_ext>71263</phone_ext>
      <email>mramonk@sjdhospitalbarcelona.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marta Ramon Krauel, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carles Lerin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

